Compare PCOR & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCOR | PEN |
|---|---|---|
| Founded | 2003 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 12.2B |
| IPO Year | 2021 | 2015 |
| Metric | PCOR | PEN |
|---|---|---|
| Price | $73.92 | $318.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 15 |
| Target Price | $89.71 | ★ $329.07 |
| AVG Volume (30 Days) | ★ 1.2M | 535.0K |
| Earning Date | 02-12-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 367.34 |
| EPS | N/A | ★ 4.14 |
| Revenue | $1,275,450,000.00 | ★ $1,333,798,000.00 |
| Revenue This Year | $16.35 | $16.77 |
| Revenue Next Year | $12.09 | $14.12 |
| P/E Ratio | ★ N/A | $77.53 |
| Revenue Growth | ★ 14.94 | 14.61 |
| 52 Week Low | $53.71 | $221.26 |
| 52 Week High | $88.92 | $321.38 |
| Indicator | PCOR | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 47.73 | 67.38 |
| Support Level | $73.64 | $307.00 |
| Resistance Level | $76.13 | $321.38 |
| Average True Range (ATR) | 2.16 | 8.62 |
| MACD | -0.20 | 0.50 |
| Stochastic Oscillator | 33.33 | 91.08 |
Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.